In the COLCOT phase III trial, low-dose colchicine reduced ischemic events after a heart attack. ConfidenceEstablished Level of evidence●●●●●○ Randomized clinical trial Observed inHuman MissionMap of aging (12 hallmarks) ConceptsChronic inflammationLow-dose colchicineCardiovascular disease